{"id":422,"date":"2019-12-05T02:19:59","date_gmt":"2019-12-05T02:19:59","guid":{"rendered":"https:\/\/drnat.com\/nd\/?p=422"},"modified":"2019-12-05T02:24:28","modified_gmt":"2019-12-05T02:24:28","slug":"prp-and-wrist-3","status":"publish","type":"post","link":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/","title":{"rendered":"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial."},"content":{"rendered":"
Sci Rep.<\/a> 2017 Dec;7(1):94. doi: 10.1038\/s41598-017-00224-6. Epub 2017 Mar 7.<\/div>\n
Wu YT<\/a>1,2, Ho TY<\/a>1, Chou YC<\/a>3, Ke MJ<\/a>1, Li TY<\/a>1,2, Huang GS<\/a>4, Chen LC<\/a>5.<\/div>\n
\n

Author information<\/a><\/h3>\n<\/div>\n
\n

Abstract<\/h3>\n
\n

Recently, a few small reports with short follow-up period have shown clinical benefits of platelet-rich plasma (PRP) for peripheral neuropathy including one pilot study and one small, non-randomized trial in patients with carpal tunnel syndrome (CTS). Therefore, we conducted a randomized, single-blind, controlled trial to assess the 6-month effect of PRP in patients with CTS. Sixty patients with unilateral mild-to-moderate CTS were randomized into two groups of 30, namely the PRP and control groups. In the PRP group, patients were injected with one dose of 3?mL of PRP using ultrasound guidance and the control group received a night splint through the study period. The primary outcome measure was the visual analog scale (VAS) and secondary outcome measures included the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) score, the cross-sectional area (CSA) of the median nerve (MN), electrophysiological findings of the MN, and finger pinch strength. The evaluation was performed before treatment and at 1, 3, and 6 months post-injection. The PRPgroup exhibited a significant reduction in the VAS score, BCTQ score, and CSA of MN compared to the those of control group 6 months post-treatment (p?<?0.05). Our study demonstrates that PRP is a safe modality that effectively relieves pain and improves disability in the patients with CTS.<\/p>\n<\/div>\n<\/div>\n

 <\/div>\n

 <\/p>\n

\n
\n
\n
Neural Regen Res<\/a>. 2015 Nov; 10(11): 1856\u20131859.<\/div>\n
doi:  10.4103\/1673-5374.165322<\/a><\/div>\n<\/div>\n
PMCID: PMC4705801<\/div>\n<\/div>\n

Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome<\/h1>\n
Michael Alexander Malahias<\/a>,1 Elizabeth O. Johnson<\/a>,2 George C. Babis<\/a>,1 and  Vasileios S. Nikolaou<\/a>, M.D., Ph.D.1,*<\/div>\n
Author information ?<\/a> Article notes ?<\/a> Copyright and License information ?<\/a><\/div>\n
This article has been cited by<\/a> other articles in PMC.<\/div>\n<\/div>\n
 <\/div>\n
\n
Go to:<\/a><\/div>\n

Abstract<\/h2>\n
\n

Both in vitro<\/em> and in vivo<\/em> experiments have confirmed that platelet-rich plasma has therapeutic effects on many neuropathies, but its effects on carpal tunnel syndrome remain poorly understood. We aimed to investigate whether single injection of platelet-rich plasma can improve the clinical symptoms of carpal tunnel syndrome. Fourteen patients presenting with median nerve injury who had suffered from mild carpal tunnel syndrome for over 3 months were included in this study. Under ultrasound guidance, 1\u20132 mL of platelet-rich plasma was injected into the region around the median nerve at the proximal edge of the carpal tunnel. At 1 month after single injection of platelet-rich plasma, Visual Analogue Scale results showed that pain almost disappeared in eight patients and it was obviously alleviated in three patients. Simultaneously, the disabilities of the arm, shoulder and hand questionnaire showed that upper limb function was obviously improved. In addition, no ultrasonographic manifestation of the carpal tunnel syndrome was found in five patients during ultrasonographic measurement of the width of the median nerve. During 3-month follow-up, the pain was not greatly alleviated in three patients. These findings show very encouraging mid-term outcomes regarding use of platelet-rich plasma for the treatment of carpal tunnel syndrome.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Sci Rep. 2017 Dec;7(1):94. doi: 10.1038\/s41598-017-00224-6. Epub 2017 Mar 7. Wu YT1,2, Ho TY1, Chou YC3, Ke MJ1, Li TY1,2, Huang GS4, Chen LC5. Author information Abstract Recently, a few small reports with short follow-up period have shown clinical benefits of platelet-rich plasma (PRP) for peripheral neuropathy including one pilot study and one small, non-randomized trial in patients with carpal tunnel syndrome (CTS). Therefore, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","ngg_post_thumbnail":0,"footnotes":""},"categories":[8,11],"tags":[],"yoast_head":"\nSix-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.\" \/>\n<meta property=\"og:description\" content=\"Sci Rep. 2017 Dec;7(1):94. doi: 10.1038\/s41598-017-00224-6. Epub 2017 Mar 7. Wu YT1,2, Ho TY1, Chou YC3, Ke MJ1, Li TY1,2, Huang GS4, Chen LC5. Author information Abstract Recently, a few small reports with short follow-up period have shown clinical benefits of platelet-rich plasma (PRP) for peripheral neuropathy including one pilot study and one small, non-randomized trial in patients with carpal tunnel syndrome (CTS). Therefore, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Dr. Nathan Ehrlich, N.D.\" \/>\n<meta property=\"article:published_time\" content=\"2019-12-05T02:19:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-12-05T02:24:28+00:00\" \/>\n<meta name=\"author\" content=\"NAt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"NAt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/\",\"url\":\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/\",\"name\":\"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.\",\"isPartOf\":{\"@id\":\"https:\/\/drnat.com\/nd\/#website\"},\"datePublished\":\"2019-12-05T02:19:59+00:00\",\"dateModified\":\"2019-12-05T02:24:28+00:00\",\"author\":{\"@id\":\"https:\/\/drnat.com\/nd\/#\/schema\/person\/0fb549d14b7bb58de157ffb3998db3dc\"},\"breadcrumb\":{\"@id\":\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/drnat.com\/nd\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/drnat.com\/nd\/#website\",\"url\":\"https:\/\/drnat.com\/nd\/\",\"name\":\"Dr. Nathan Ehrlich, N.D.\",\"description\":\"Physician \/ Musician\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/drnat.com\/nd\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/drnat.com\/nd\/#\/schema\/person\/0fb549d14b7bb58de157ffb3998db3dc\",\"name\":\"NAt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/drnat.com\/nd\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/68a842d3599799d23ca9a8930a405aa1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/68a842d3599799d23ca9a8930a405aa1?s=96&d=mm&r=g\",\"caption\":\"NAt\"},\"url\":\"https:\/\/drnat.com\/nd\/author\/NAt\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/","og_locale":"en_US","og_type":"article","og_title":"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.","og_description":"Sci Rep. 2017 Dec;7(1):94. doi: 10.1038\/s41598-017-00224-6. Epub 2017 Mar 7. Wu YT1,2, Ho TY1, Chou YC3, Ke MJ1, Li TY1,2, Huang GS4, Chen LC5. Author information Abstract Recently, a few small reports with short follow-up period have shown clinical benefits of platelet-rich plasma (PRP) for peripheral neuropathy including one pilot study and one small, non-randomized trial in patients with carpal tunnel syndrome (CTS). Therefore, […]","og_url":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/","og_site_name":"Dr. Nathan Ehrlich, N.D.","article_published_time":"2019-12-05T02:19:59+00:00","article_modified_time":"2019-12-05T02:24:28+00:00","author":"NAt","twitter_card":"summary_large_image","twitter_misc":{"Written by":"NAt","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/","url":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/","name":"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. - Dr. Nathan Ehrlich, N.D.","isPartOf":{"@id":"https:\/\/drnat.com\/nd\/#website"},"datePublished":"2019-12-05T02:19:59+00:00","dateModified":"2019-12-05T02:24:28+00:00","author":{"@id":"https:\/\/drnat.com\/nd\/#\/schema\/person\/0fb549d14b7bb58de157ffb3998db3dc"},"breadcrumb":{"@id":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/drnat.com\/nd\/prp-and-wrist-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/drnat.com\/nd\/prp-and-wrist-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/drnat.com\/nd\/"},{"@type":"ListItem","position":2,"name":"Six-month efficacy of platelet-rich plasma for\u00a0carpal tunnel syndrome: A prospective randomized, single-blind controlled trial."}]},{"@type":"WebSite","@id":"https:\/\/drnat.com\/nd\/#website","url":"https:\/\/drnat.com\/nd\/","name":"Dr. Nathan Ehrlich, N.D.","description":"Physician \/ Musician","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/drnat.com\/nd\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/drnat.com\/nd\/#\/schema\/person\/0fb549d14b7bb58de157ffb3998db3dc","name":"NAt","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/drnat.com\/nd\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/68a842d3599799d23ca9a8930a405aa1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68a842d3599799d23ca9a8930a405aa1?s=96&d=mm&r=g","caption":"NAt"},"url":"https:\/\/drnat.com\/nd\/author\/NAt\/"}]}},"_links":{"self":[{"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/posts\/422"}],"collection":[{"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/comments?post=422"}],"version-history":[{"count":2,"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/posts\/422\/revisions"}],"predecessor-version":[{"id":435,"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/posts\/422\/revisions\/435"}],"wp:attachment":[{"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/media?parent=422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/categories?post=422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drnat.com\/nd\/wp-json\/wp\/v2\/tags?post=422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}